What's new in IDIS:

 • New Drugs

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Advisory Committee Meetings

 • Continuing Education Articles

 • Priority Clinical Practice Guidelines

 

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

Notice: IDIS database discontinuation December 31, 2014.   Read more.

IDIS Logo   IDIS Monthly Update Information - July 2014

NEW DRUG TERM
AMG-108
AVP-21-D-9
BINIMETINIB
DEXMECAMYLAMINE
DULAGLUTIDE
EBI-005
ENCORAFENIB
ERAVACYCLINE
ERTUGLIFLOZIN
LC-1699
MDCO-2010
PH-94-B
POLYDEOXYRIBONUCLEOTIDE
RAF-265
SEMAGLUTIDE
VX-765

CODE
82000901
82000902
10121074
12080108
68200032
14000427
10121075
8122962
68200463
44100119
20121630
28240888
14000605
10121076
68200033
14000428



DRUG NAME/CODE CHANGES

OLD TERM & CODE
AKR-501 95000350

NEW TERM & CODE
AVATROMBOPAG 14000097


FDA APPROVAL PACKAGES

Article Numbers 718298-718312: Efinaconazole, Jublia Topical Solution, FDA Approval Package for NDA 203567. FDA Approval Package 2014.

Article Numbers 718221-718234: Vorapaxar, Zontivity, FDA Approval Package for NDA 204886. FDA Approval Package 2014.

Article Numbers 718205-718220: Vedolizumab, Entyvio, FDA Approval Package for BLA 125476. FDA Approval Package 2014.

Article Numbers 718189-718204: Dalbavancin Hydrochloride, Dalvance, FDA Approval Package for NDA 021883. FDA Approval Package 2014.


ADVISORY COMMITTEE MEETINGS

Article Numbers 718237-718243: Anesthetic and Analgesic Drug Products Advisory Committee Meeting, June 11-12, 2014. FDA Advisory Committee 2014.


CONTINUING EDUCATION ARTICLES

Article Number 717523: Anonymous. In Brief: Lowering the Dose of Lunesta (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 717521-717523]. Med Lett Drugs Ther 2014, 56:48.

Article Number 717522: Anonymous. Sublingual Immunotherapy for Allergic Rhinitis (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 717521-717523]. Med Lett Drugs Ther 2014, 56:47-48.

Article Number 717521: Anonymous. Extended-Release Hydrocodone (Zohydro ER) for Pain (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 717521-717523]. Med Lett Drugs Ther 2014, 56:45-46.

Article Number 717203: Anonymous. Sorafenib (Nexavar) for Thyroid Cancer ( 0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 717201-717203]. Med Lett Drugs Ther 2014, 56:43-44.

Article Number 717202: (Letter To Ed), Anonymous. Eslicarbazepine Acetate (Aptiom) for Epilepsy ( 0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 717201- 717203]. Med Lett Drugs Ther 2014, 56:42-43.

Article Number 717201: Anonymous. Apremilast (Otezla) for Psoriatic Arthritis ( 0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 717201- 717203]. Med Lett Drugs Ther 2014, 56:41-42.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 718235: Anonymous. Full Guideline. Atrial Fibrillation: The Management of Atrial Fibrillation. NICE Clinical Guideline No. 180 (Ref Art 718236). NICE Clin Guidel 2014.

Article Number 717818: Sousa-Uva M, Storey R, Huber K, Falk V, Et Al. Expert Position Paper on the Management of Antiplatelet Therapy in Patients Undergoing Coronary Artery Bypass Graft Surgery. Eur Heart J 2014, 35:1510-1514C.


College of Pharmacy